Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D003342:Corpus Striatum / Q000187:drug effects; D004311:Double-Blind Method; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology*; D004576:Electromyography; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000188:drug therapy; D011954:Receptors, Dopamine / Q000187:drug effects; D011963:Receptors, GABA-A / Q000187:drug effects; D014202:Tremor / Q000139:chemically induced* / Q000188:drug therapy; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; C017985:progabide; D005680:gamma-Aminobutyric Acid